In most cases, the active site is rearranged or complemented by complex formation to allow an efficient phosphoryl transfer reaction.
Soluble SC5b-9 complexent complevelsvels increased in the plasma of women during parturition, and complement C5b-9 complexes were deposited on fetal membranes.
Eculizumab therefore inhibits the cleavage of C5 to C5a and C5b by the C5 convertase, which prevents the generation of the terminal complement complex C5b-9.
Activation of the complement system, which forms a major part of the innate immune system, results in the formation of the terminal complement complex.
Complement activation study revealed minimum terminal complement complex (TCC) concentration for PLLA/Gel and PLLA/Gel/HA (617.33 and 654.13 ng/mL respectively).
In controls, deposition of ficolin-3, C4, C3 and the terminal complement complex (TCC) was measured in an assay based on acetylated albumin as matrix.
Measurements and Main Results: Hemoglobin, hematocrit, leukocyte count, platelet count, terminal complement complex, complement activation, myeloperoxidase, β-thromboglobulin, prothrombin fragment 1.2, plasmin-antiplasmin, heparin concentration, activated coagulation time, and fibrinogen concentration were measured.
An increase in complement Factor H adsorption was observed at high shear region; however, no change in the complete complement activation was observed in the presence of shear stress as indicated by the protein S-terminal complement complex level.
The mechanism(s) that initiates complement activation is not clearly known, although loss of CD59 (protectin) from cells compromised by ischemia/reperfusion may contribute to direct damage of the coronary vascular bed by the terminal complement complex.
The sulfated alginate microbeads exhibited a complement inert nature with no induction of terminal complement complex (TCC) above the values in freshly drawn blood and low surface accumulation of C3/C3b/iC3b.
